Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

avidity biosciences

POPULAR ARTICLES

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635

Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies

Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies

Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association Clinical & Scientific Conference

Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association Clinical & Scientific Conference

LATEST ARTICLES

Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders

Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders

Avidity Biosciences Announces Expected Record Date for Spin-Off

Avidity Biosciences Announces Expected Record Date for Spin-Off

Avidity Biosciences Announces U.S. Managed Access Program for Investigational Therapy del-zota in DMD44

Avidity Biosciences Announces U.S. Managed Access Program for Investigational Therapy del-zota in DMD44

Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights

Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG

Companion Animal Diagnostics Market Size to Reach USD 14.47 Billion by 2034

Companion Animal Diagnostics Market Size to Reach USD 14.47 Billion by 2034

Avidity Biosciences to Participate in Upcoming Investor Conference

Avidity Biosciences to Participate in Upcoming Investor Conference

Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026

Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026

Latest News

SAGA Metals Announces Closing of Over-Subscribed $10.2 Million Non-Brokered Private Placement

Finlay Minerals Ltd. engages German Mining Networks and renews engagement with Investing News Network

Nevada Sunrise Investor Relations Agreement

TomaGold Announces Closing of Second and Final Tranche of Private Placement

LAURION Retains SMARTIR Marketing Ltd. to Drive Investor Awareness Ahead of Active 2026 Exploration Program

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Morningstar

MORN

BriaCell Therapeutics

BriaCell Therapeutics (BCT:CC)

BCT:CC

EraNova Metals

EraNova Metals (NOVA:CC)

NOVA:CC

MetalSource Mining

MetalSource Mining (MSM:CC)

MSM:CC

LaFleur Minerals

LaFleur Minerals (LFLR:CC)

LFLR:CC

ARC Resources

ARX:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES